T0	Noun_Phrase 22 41	Trichothiodystrophy
T1	IDENTITY_chain 22 41	Trichothiodystrophy
T2	IDENTITY_chain 45 74	Homozygous Lethal Xpd Alleles
T3	Noun_Phrase 45 74	Homozygous Lethal Xpd Alleles
T4	Noun_Phrase 95 118	compound heterozygosity
T5	IDENTITY_chain 95 118	compound heterozygosity
T6	Noun_Phrase 139 184	two different mutant alleles of the same gene
T7	IDENTITY_chain 139 184	two different mutant alleles of the same gene
T8	Noun_Phrase 153 159	mutant
T9	IDENTITY_chain 153 159	mutant
T10	Noun_Phrase 199 204	human
T11	IDENTITY_chain 199 204	human
T12	Noun_Phrase 199 222	human recessive disease
T13	IDENTITY_chain 199 222	human recessive disease
T14	Noun_Phrase 224 227	its
T15	Noun_Phrase 224 292	its potential to impact disease outcome has not been well documented
T16	IDENTITY_chain 224 292	its potential to impact disease outcome has not been well documented
T17	Noun_Phrase 294 298	This
T18	Noun_Phrase 414 425	environment
T19	IDENTITY_chain 414 425	environment
T20	Noun_Phrase 429 447	genetic background
T21	IDENTITY_chain 429 447	genetic background
T22	Noun_Phrase 449 451	We
T23	IDENTITY_chain 449 451	We
T24	Noun_Phrase 565 568	XPD
T25	IDENTITY_chain 565 568	XPD
T26	Noun_Phrase 592 619	compound heterozygous mouse
T27	IDENTITY_chain 592 619	compound heterozygous mouse
T28	Noun_Phrase 614 619	mouse
T29	IDENTITY_chain 614 619	mouse
T30	Noun_Phrase 643 666	this essential helicase
T31	Noun_Phrase 706 725	basal transcription
T32	IDENTITY_chain 706 725	basal transcription
T33	Noun_Phrase 855 857	We
T34	Noun_Phrase 899 919	organismal phenotype
T35	IDENTITY_chain 899 919	organismal phenotype
T36	Noun_Phrase 1019 1048	homozygous lethal Xpd alleles
T37	Noun_Phrase 1076 1092	disease symptoms
T38	IDENTITY_chain 1076 1092	disease symptoms
T39	Noun_Phrase 1098 1103	their
T40	Noun_Phrase 1114 1133	basal transcription
T41	IDENTITY_chain 1299 1327	interallelic complementation
T42	APPOS_relation 1299 1327	interallelic complementation
T43	Noun_Phrase 1299 1327	interallelic complementation
T44	Noun_Phrase 1329 1396	a phenomenon rarely reported at clinically relevant loci in mammals
T45	Noun_Phrase 1389 1396	mammals
T46	IDENTITY_chain 1389 1396	mammals
T47	Noun_Phrase 1398 1401	Our
T48	Noun_Phrase 1398 1406	Our data
T49	IDENTITY_chain 1398 1406	Our data
T50	Noun_Phrase 1455 1459	null
T51	IDENTITY_chain 1455 1459	null
T52	Noun_Phrase 1472 1475	XPD
T53	Noun_Phrase 1533 1550	recessive alleles
T54	IDENTITY_chain 1533 1550	recessive alleles
T55	Noun_Phrase 1615 1622	mammals
T56	Noun_Phrase 1639 1667	Interallelic complementation
T57	Noun_Phrase 1796 1799	its
T58	Noun_Phrase 1842 1845	its
T59	Noun_Phrase 1899 1904	human
T60	Noun_Phrase 1899 1912	human disease
T61	IDENTITY_chain 1899 1912	human disease
T62	Noun_Phrase 2264 2286	Compound heterozygotes
T63	Noun_Phrase 2312 2357	two different mutant alleles of the same gene
T64	Noun_Phrase 2326 2332	mutant
T65	Noun_Phrase 2389 2398	wild-type
T66	APPOS_relation 2389 2398	wild-type
T67	IDENTITY_chain 2389 2398	wild-type
T68	Noun_Phrase 2400 2402	wt
T69	Noun_Phrase 2413 2459	genetic interactions between recessive alleles
T70	IDENTITY_chain 2413 2459	genetic interactions between recessive alleles
T71	Noun_Phrase 2442 2459	recessive alleles
T72	Noun_Phrase 2558 2586	interallelic complementation
T73	Noun_Phrase 2613 2629	disease symptoms
T74	Noun_Phrase 2633 2661	interallelic complementation
T75	Noun_Phrase 2744 2772	interallelic complementation
T76	Noun_Phrase 2744 2799	interallelic complementation or other biallelic effects
T77	IDENTITY_chain 2744 2799	interallelic complementation or other biallelic effects
T78	Noun_Phrase 2803 2808	human
T79	Noun_Phrase 2803 2816	human disease
T80	Noun_Phrase 2870 2882	such effects
T81	Noun_Phrase 2888 2899	environment
T82	Noun_Phrase 2888 2922	environment and genetic background
T83	IDENTITY_chain 2888 2922	environment and genetic background
T84	Noun_Phrase 2904 2922	genetic background
T85	Noun_Phrase 2925 2928	XPD
T86	Noun_Phrase 2975 3016	basal transcription/DNA repair factor IIH
T87	IDENTITY_chain 2975 3016	basal transcription/DNA repair factor IIH
T88	APPOS_relation 2975 3016	basal transcription/DNA repair factor IIH
T89	Noun_Phrase 3018 3023	TFIIH
T90	APPOS_relation 3018 3023	TFIIH
T91	Noun_Phrase 3026 3218	a ten-subunit, multifunctional complex that is essential for multiple processes, including basal transcription initiation and DNA damage repair via the nucleotide excision repair (NER) pathway
T92	Noun_Phrase 3117 3136	basal transcription
T93	Noun_Phrase 3178 3204	nucleotide excision repair
T94	APPOS_relation 3178 3204	nucleotide excision repair
T95	IDENTITY_chain 3178 3204	nucleotide excision repair
T96	Noun_Phrase 3206 3209	NER
T97	Noun_Phrase 3241 3244	XPD
T98	Noun_Phrase 3268 3273	TFIIH
T99	Noun_Phrase 3349 3370	xeroderma pigmentosum
T100	APPOS_relation 3349 3370	xeroderma pigmentosum
T101	IDENTITY_chain 3349 3370	xeroderma pigmentosum
T102	Noun_Phrase 3372 3374	XP
T103	Noun_Phrase 3377 3379	XP
T104	Noun_Phrase 3394 3411	Cockayne syndrome
T105	APPOS_relation 3394 3411	Cockayne syndrome
T106	IDENTITY_chain 3394 3411	Cockayne syndrome
T107	Noun_Phrase 3413 3415	CS
T108	Noun_Phrase 3422 3441	trichothiodystrophy
T109	APPOS_relation 3422 3441	trichothiodystrophy
T110	Noun_Phrase 3443 3446	TTD
T111	Noun_Phrase 3449 3450	8
T112	IDENTITY_chain 3449 3450	8
T113	Noun_Phrase 3456 3458	XP
T114	Noun_Phrase 3658 3660	CS
T115	Noun_Phrase 3665 3668	TTD
T116	Noun_Phrase 3885 3887	12
T117	Noun_Phrase 3888 3890	15
T118	IDENTITY_chain 3888 3890	15
T119	Noun_Phrase 3907 3910	TTD
T120	Noun_Phrase 4000 4002	13
T121	IDENTITY_chain 4000 4002	13
T122	Noun_Phrase 4022 4041	basal transcription
T123	Noun_Phrase 4073 4075	16
T124	IDENTITY_chain 4073 4075	16
T125	Noun_Phrase 4076 4078	17
T126	IDENTITY_chain 4076 4078	17
T127	Noun_Phrase 4134 4136	XP
T128	Noun_Phrase 4151 4193	the neurodevelopmental complications of CS
T129	Noun_Phrase 4191 4193	CS
T130	Noun_Phrase 4195 4199	XPCS
T131	APPOS_relation 4195 4199	XPCS
T132	IDENTITY_chain 4195 4199	XPCS
T133	Noun_Phrase 4248 4519	Many XPD mutations are associated with an exclusive disease phenotype (e.g., XPDR722W with TTD and XPDR683W with XP) and are thus viewed as causative of the corresponding syndromes. Alleles not associated exclusively with one disorder are considered “likely null” alleles
T134	IDENTITY_chain 4248 4519	Many XPD mutations are associated with an exclusive disease phenotype (e.g., XPDR722W with TTD and XPDR683W with XP) and are thus viewed as causative of the corresponding syndromes. Alleles not associated exclusively with one disorder are considered “likely null” alleles
T135	Noun_Phrase 4253 4256	XPD
T136	Noun_Phrase 4339 4342	TTD
T137	Noun_Phrase 4347 4363	XPDR683W with XP
T138	IDENTITY_chain 4347 4363	XPDR683W with XP
T139	Noun_Phrase 4361 4363	XP
T140	Noun_Phrase 4430 4519	Alleles not associated exclusively with one disorder are considered “likely null” alleles
T141	IDENTITY_chain 4430 4519	Alleles not associated exclusively with one disorder are considered “likely null” alleles
T142	Noun_Phrase 4521 4523	19
T143	IDENTITY_chain 4521 4523	19
T144	Noun_Phrase 4537 4550	these alleles
T145	Noun_Phrase 4636 4640	null
T146	Noun_Phrase 4653 4676	the XPD homologue rad15
T147	IDENTITY_chain 4653 4676	the XPD homologue rad15
T148	Noun_Phrase 4657 4660	XPD
T149	Noun_Phrase 4744 4746	19
T150	Noun_Phrase 4749 4779	This classification of alleles
T151	Noun_Phrase 4803 4807	null
T152	Noun_Phrase 4831 4833	we
T153	Noun_Phrase 4874 4877	XPD
T154	Noun_Phrase 4934 4936	XP
T155	Noun_Phrase 5033 5035	XP
T156	Noun_Phrase 5040 5043	TTD
T157	Noun_Phrase 5045 5046	8
T158	Noun_Phrase 5144 5166	compound heterozygotes
T159	IDENTITY_chain 5144 5166	compound heterozygotes
T160	Noun_Phrase 5181 5183	we
T161	Noun_Phrase 5194 5211;5223 5258	a TTD mouse model that phenocopies the human syndrome
T162	Noun_Phrase 5196 5199	TTD
T163	Noun_Phrase 5200 5205	mouse
T164	Noun_Phrase 5213 5221	XPDR722W
T165	APPOS_relation 5213 5221	XPDR722W
T166	IDENTITY_chain 5213 5221	XPDR722W
T167	Noun_Phrase 5244 5249	human
T168	Noun_Phrase 5260 5262	15
T169	Noun_Phrase 5263 5265	21
T170	IDENTITY_chain 5263 5265	21
T171	Noun_Phrase 5273 5275	we
T172	Noun_Phrase 5301 5557	additional mutant Xpd alleles that fail to support viability on their own but nevertheless ameliorate TTD-associated premature segmental ageing, cutaneous features, cellular DNA repair capacity, and UV survival when present in a compound heterozygote state
T173	IDENTITY_chain 5301 5557	additional mutant Xpd alleles that fail to support viability on their own but nevertheless ameliorate TTD-associated premature segmental ageing, cutaneous features, cellular DNA repair capacity, and UV survival when present in a compound heterozygote state
T174	Noun_Phrase 5312 5318	mutant
T175	Noun_Phrase 5365 5370	their
T176	Noun_Phrase 5446 5455	cutaneous
T177	Noun_Phrase 5446 5464	cutaneous features
T178	IDENTITY_chain 5446 5464	cutaneous features
T179	Noun_Phrase 5500 5502	UV
T180	IDENTITY_chain 5500 5502	UV
T181	Noun_Phrase 5500 5511	UV survival
T182	Noun_Phrase 5530 5551	compound heterozygote
T183	Noun_Phrase 5611 5613	We
T184	Noun_Phrase 5624 5704;5716 5747	an Xpd knock-in allele with a point mutation encoding a single amino acid change found in the XPCS patient XPCS2
T185	Noun_Phrase 5706 5714	XPDG602D
T186	APPOS_relation 5706 5714	XPDG602D
T187	IDENTITY_chain 5706 5714	XPDG602D
T188	Noun_Phrase 5729 5733	XPCS
T189	Noun_Phrase 5729 5747	XPCS patient XPCS2
T190	IDENTITY_chain 5729 5747	XPCS patient XPCS2
T191	Noun_Phrase 5749 5755;5759 5761	Figure 1C
T192	IDENTITY_chain 5749 5755;5759 5761	Figure 1C
T193	Noun_Phrase 5749 5758	Figure 1A
T194	IDENTITY_chain 5749 5758	Figure 1A
T195	Noun_Phrase 5764 5768	mRNA
T196	IDENTITY_chain 5764 5768	mRNA
T197	Noun_Phrase 5826 5846	embryonic stem cells
T198	IDENTITY_chain 5826 5846	embryonic stem cells
T199	Noun_Phrase 5858 5867	Figure 1D
T200	IDENTITY_chain 5858 5867	Figure 1D
T201	Noun_Phrase 5935 5937	wt
T202	Noun_Phrase 5938 5942	mRNA
T203	Noun_Phrase 6008 6042	the testis of heterozygous animals
T204	IDENTITY_chain 6008 6042	the testis of heterozygous animals
T205	Noun_Phrase 6044 6053	Figure 1E
T206	IDENTITY_chain 6044 6053	Figure 1E
T207	Noun_Phrase 6064 6077	patient XPCS2
T208	Noun_Phrase 6064 6118;6130 6160	patient XPCS2 was a hemizygote with mutant XPD protein expressed from a single allele
T209	Noun_Phrase 6100 6106	mutant
T210	Noun_Phrase 6107 6110	XPD
T211	Noun_Phrase 6120 6128	XPDG602D
T212	APPOS_relation 6120 6128	XPDG602D
T213	Noun_Phrase 6260 6266	mutant
T214	Noun_Phrase 6323 6341	embryonic day 13.5
T215	APPOS_relation 6323 6341	embryonic day 13.5
T216	Noun_Phrase 6343 6348	E13.5
T217	Noun_Phrase 6367 6374	Table 1
T218	IDENTITY_chain 6367 6374	Table 1
T219	Noun_Phrase 6408 6414	mutant
T220	Noun_Phrase 6445 6462	homozygous lethal
T221	APPOS_relation 6464 6469	†XPCS
T222	Noun_Phrase 6464 6469	†XPCS
T223	IDENTITY_chain 6464 6469	†XPCS
T224	Noun_Phrase 6472 6765	Homozygous lethality of the XPCS allele is likely due to reduced levels of expression of this essential protein as a result of gene targeting (Figure 1A) rather than to the mutation itself. Xpd ablation (XpdKO/KO) is similarly incompatible with life beyond the earliest stages of embryogenesis
T225	IDENTITY_chain 6472 6765	Homozygous lethality of the XPCS allele is likely due to reduced levels of expression of this essential protein as a result of gene targeting (Figure 1A) rather than to the mutation itself. Xpd ablation (XpdKO/KO) is similarly incompatible with life beyond the earliest stages of embryogenesis
T226	Noun_Phrase 6500 6504	XPCS
T227	Noun_Phrase 6561 6583	this essential protein
T228	Noun_Phrase 6615 6624	Figure 1A
T229	Noun_Phrase 6662 6674	Xpd ablation
T230	APPOS_relation 6662 6674	Xpd ablation
T231	Noun_Phrase 6676 6684	XpdKO/KO
T232	Noun_Phrase 6767 6769	22
T233	IDENTITY_chain 6767 6769	22
T234	Noun_Phrase 6788 6807	this interpretation
T235	Noun_Phrase 6852 6860	XPDR683W
T236	Noun_Phrase 6917 6923	humans
T237	Noun_Phrase 7017 7023;7027 7029	Figure 1C
T238	Noun_Phrase 7017 7026	Figure 1A
T239	Noun_Phrase 7031 7038	Table 1
T240	IDENTITY_chain 7040 7056	unpublished data
T241	Noun_Phrase 7040 7056	unpublished data
T242	Noun_Phrase 7192 7199	XpdXPCS
T243	IDENTITY_chain 7192 7199	XpdXPCS
T244	Noun_Phrase 7200 7204	mRNA
T245	Noun_Phrase 7216 7246	viable homozygous XpdXPCS/XPCS
T246	Noun_Phrase 7234 7246	XpdXPCS/XPCS
T247	APPOS_relation 7248 7262	XPDG602D/G602D
T248	Noun_Phrase 7248 7262	XPDG602D/G602D
T249	Noun_Phrase 7273 7275	23
T250	IDENTITY_chain 7273 7275	23
T251	Noun_Phrase 7306 7311	Mouse
T252	Noun_Phrase 7323 7324	A
T253	Noun_Phrase 7411 7413	wt
T254	Noun_Phrase 7427 7432	mouse
T255	Noun_Phrase 7451 7453	wt
T256	Noun_Phrase 7507 7512;7520 7522	exons 19
T257	IDENTITY_chain 7507 7512;7520 7522	exons 19
T258	Noun_Phrase 7527 7536	the 3′UTR
T259	IDENTITY_chain 7527 7536	the 3′UTR
T260	Noun_Phrase 7664 7670	XpdTTD
T261	IDENTITY_chain 7664 7670	XpdTTD
T262	Noun_Phrase 7696 7705	base pair
T263	APPOS_relation 7696 7705	base pair
T264	Noun_Phrase 7707 7709	bp
T265	Noun_Phrase 7711 7716	human
T266	Noun_Phrase 7717 7720	XPD
T267	Noun_Phrase 7744 7751	exon 22
T268	IDENTITY_chain 7744 7751	exon 22
T269	Noun_Phrase 7792 7799;7808 7816	the TTD mutation
T270	Noun_Phrase 7796 7799	TTD
T271	Noun_Phrase 7801 7806	R722W
T272	APPOS_relation 7801 7806	R722W
T273	Noun_Phrase 7889 7898	the 3′UTR
T274	Noun_Phrase 7974 8009	the β-globin polyadenylation signal
T275	APPOS_relation 7974 8009	the β-globin polyadenylation signal
T276	Noun_Phrase 8011 8017	PolyA*
T277	Noun_Phrase 8024 8034;8048 8064	the Xpd†XP targeted alleles
T278	IDENTITY_chain 8024 8034;8048 8064	the Xpd†XP targeted alleles
T279	Noun_Phrase 8028 8034	Xpd†XP
T280	IDENTITY_chain 8028 8034	Xpd†XP
T281	Noun_Phrase 8039 8047	Xpd†XPCS
T282	IDENTITY_chain 8039 8047	Xpd†XPCS
T283	Noun_Phrase 8039 8064	Xpd†XPCS targeted alleles
T284	IDENTITY_chain 8039 8064	Xpd†XPCS targeted alleles
T285	Noun_Phrase 8091 8095;8137 8146	XPCS mutations
T286	APPOS_relation 8091 8095;8137 8146	XPCS mutations
T287	Noun_Phrase 8091 8095	XPCS
T288	Noun_Phrase 8097 8111	G602D-encoding
T289	Noun_Phrase 8117 8119;8137 8146	XP mutations
T290	APPOS_relation 8117 8119;8137 8146	XP mutations
T291	Noun_Phrase 8117 8119	XP
T292	Noun_Phrase 8121 8135	R683W-encoding
T293	Noun_Phrase 8150 8155;8163 8165	exons 22
T294	Noun_Phrase 8150 8158	exons 19
T295	Noun_Phrase 8181 8240	The unique 3′ probe located outside the targeting construct
T296	IDENTITY_chain 8181 8240	The unique 3′ probe located outside the targeting construct
T297	Noun_Phrase 8417 8419	wt
T298	Noun_Phrase 8421 8432	Xpd†XPCS/wt
T299	IDENTITY_chain 8421 8432	Xpd†XPCS/wt
T300	Noun_Phrase 8503 8515	the 3′ probe
T301	Noun_Phrase 8529 8530	A
T302	Noun_Phrase 8533 8546	The wt allele
T303	Noun_Phrase 8537 8539	wt
T304	Noun_Phrase 8560 8568	kilobase
T305	APPOS_relation 8560 8568	kilobase
T306	Noun_Phrase 8570 8572	kb
T307	Noun_Phrase 8597 8605;8617 8633	targeted Xpd†XPCS alleles
T308	Noun_Phrase 8597 8612;8626 8633	targeted Xpd†XP alleles
T309	Noun_Phrase 8606 8612	Xpd†XP
T310	Noun_Phrase 8617 8625	Xpd†XPCS
T311	Noun_Phrase 8661 8662	C
T312	Noun_Phrase 8678 8680	wt
T313	Noun_Phrase 8715 8722;8735 8737	primers mR
T314	IDENTITY_chain 8715 8722;8735 8737	primers mR
T315	Noun_Phrase 8755 8756	A
T316	Noun_Phrase 8813 8814	D
T317	Noun_Phrase 8836 8840	mRNA
T318	Noun_Phrase 8890 8895	†XPCS
T319	Noun_Phrase 8907 8926	embryonic stem cell
T320	Noun_Phrase 8940 8947;9001 9003	primers mR
T321	Noun_Phrase 9021 9022	A
T322	Noun_Phrase 9058 9059	E
T323	Noun_Phrase 9111 9120;9151 9189;9230 9234	testis of heterozygous Xpd†XPCS/wt and XpdTTD/wt mice
T324	Noun_Phrase 9111 9120;9195 9234	testis of compound heterozygous Xpd†XPCS/TTD mice
T325	IDENTITY_chain 9111 9120;9195 9234	testis of compound heterozygous Xpd†XPCS/TTD mice
T326	Noun_Phrase 9121 9131;9139 9149;9230 9234	homozygous XpdTTD/TTD mice
T327	IDENTITY_chain 9121 9131;9139 9149;9230 9234	homozygous XpdTTD/TTD mice
T328	Noun_Phrase 9132 9134	wt
T329	IDENTITY_chain 9139 9149	XpdTTD/TTD
T330	Noun_Phrase 9139 9149	XpdTTD/TTD
T331	Noun_Phrase 9164 9175	Xpd†XPCS/wt
T332	Noun_Phrase 9180 9189	XpdTTD/wt
T333	Noun_Phrase 9195 9234	compound heterozygous Xpd†XPCS/TTD mice
T334	IDENTITY_chain 9195 9234	compound heterozygous Xpd†XPCS/TTD mice
T335	Noun_Phrase 9217 9229	Xpd†XPCS/TTD
T336	IDENTITY_chain 9217 9229	Xpd†XPCS/TTD
T337	Noun_Phrase 9277 9282	mouse
T338	Noun_Phrase 9339 9341	wt
T339	Noun_Phrase 9343 9351	Xpd†XPCS
T340	Noun_Phrase 9357 9363	XpdTTD
T341	Noun_Phrase 9357 9371	XpdTTD alleles
T342	IDENTITY_chain 9357 9371	XpdTTD alleles
T343	Noun_Phrase 9390 9406	ethidium bromide
T344	APPOS_relation 9390 9406	ethidium bromide
T345	Noun_Phrase 9408 9412	EtBr
T346	Noun_Phrase 9482 9489	Table 1
T347	Noun_Phrase 9595 9599	Null
T348	Noun_Phrase 9643 9647	Skin
T349	IDENTITY_chain 9643 9647	Skin
T350	Noun_Phrase 9653 9657	Hair
T351	IDENTITY_chain 9653 9657	Hair
T352	Noun_Phrase 9670 9673	TTD
T353	Noun_Phrase 9670 9673	TTD
T354	Noun_Phrase 9721 9725	null
T355	Noun_Phrase 9764 9784	organismal phenotype
T356	Noun_Phrase 9786 9788	we
T357	Noun_Phrase 9798 9816	an Xpd†XPCS allele
T358	IDENTITY_chain 9798 9816	an Xpd†XPCS allele
T359	Noun_Phrase 9801 9809	Xpd†XPCS
T360	Noun_Phrase 9831 9837	XpdTTD
T361	Noun_Phrase 9908 9922	hemizygous TTD
T362	IDENTITY_chain 9908 9922	hemizygous TTD
T363	Noun_Phrase 9946 9965	Xpd knockout allele
T364	APPOS_relation 9946 9965	Xpd knockout allele
T365	IDENTITY_chain 9946 9965	Xpd knockout allele
T366	Noun_Phrase 9967 9976	XpdTTD/KO
T367	Noun_Phrase 9979 10018	compound heterozygous XpdTTD/†XPCS mice
T368	Noun_Phrase 10001 10013	XpdTTD/†XPCS
T369	Noun_Phrase 10084 10103	the Xpd†XPCS allele
T370	Noun_Phrase 10088 10096	Xpd†XPCS
T371	Noun_Phrase 10124 10167	the testis of compound heterozygous animals
T372	Noun_Phrase 10193 10210	the XpdTTD allele
T373	Noun_Phrase 10197 10203	XpdTTD
T374	Noun_Phrase 10237 10239	wt
T375	Noun_Phrase 10252 10261	Figure 1E
T376	Noun_Phrase 10355 10361	mutant
T377	Noun_Phrase 10371 10374	XPD
T378	Noun_Phrase 10426 10428	we
T379	Noun_Phrase 10477 10480	XPD
T380	Noun_Phrase 10544 10548	mRNA
T381	Noun_Phrase 10561 10598	the homozygous lethal Xpd†XPCS allele
T382	IDENTITY_chain 10561 10598	the homozygous lethal Xpd†XPCS allele
T383	Noun_Phrase 10583 10591	Xpd†XPCS
T384	Noun_Phrase 10680 10692	XpdTTD/†XPCS
T385	Noun_Phrase 10741 10759	cutaneous features
T386	Noun_Phrase 10789 10803	hemizygous TTD
T387	Noun_Phrase 10810 10816;10820 10822	Figure 2C
T388	IDENTITY_chain 10810 10816;10820 10822	Figure 2C
T389	Noun_Phrase 10810 10819	Figure 2A
T390	IDENTITY_chain 10810 10819	Figure 2A
T391	Noun_Phrase 10847 10857;10874 10878	XpdTTD/TTD mice
T392	Noun_Phrase 10847 10857	XpdTTD/TTD
T393	IDENTITY_chain 10847 10857;10874 10878	XpdTTD/TTD mice
T394	Noun_Phrase 10847 10878	XpdTTD/TTD (and XpdTTD/KO) mice
T395	IDENTITY_chain 10847 10878	XpdTTD/TTD (and XpdTTD/KO) mice
T396	Noun_Phrase 10863 10872	XpdTTD/KO
T397	Noun_Phrase 10916 10936	the first hair cycle
T398	IDENTITY_chain 10916 10936	the first hair cycle
T399	Noun_Phrase 10991 10996	their
T400	Noun_Phrase 11004 11006	21
T401	Noun_Phrase 11009 11048	compound heterozygous XpdTTD/†XPCS mice
T402	Noun_Phrase 11031 11043	XpdTTD/†XPCS
T403	Noun_Phrase 11086 11106	the first hair cycle
T404	Noun_Phrase 11137 11146	Figure 2A
T405	Noun_Phrase 11190 11202	XpdTTD/†XPCS
T406	Noun_Phrase 11324 11340	unpublished data
T407	Noun_Phrase 11343 11362	Amino acid analysis
T408	IDENTITY_chain 11343 11362	Amino acid analysis
T409	Noun_Phrase 11378 11386	cysteine
T410	IDENTITY_chain 11378 11386	cysteine
T411	Noun_Phrase 11413 11425	XpdTTD/†XPCS
T412	Noun_Phrase 11413 11430	XpdTTD/†XPCS mice
T413	IDENTITY_chain 11413 11430	XpdTTD/†XPCS mice
T414	Noun_Phrase 11465 11475	XpdTTD/TTD
T415	Noun_Phrase 11465 11483	XpdTTD/TTD animals
T416	IDENTITY_chain 11465 11483	XpdTTD/TTD animals
T417	Noun_Phrase 11508 11510	wt
T418	Noun_Phrase 11508 11516	wt level
T419	IDENTITY_chain 11508 11516	wt level
T420	Noun_Phrase 11518 11527	Figure 2C
T421	Noun_Phrase 11530 11533	TTD
T422	Noun_Phrase 11530 11545	TTD hemizygotes
T423	APPOS_relation 11530 11545	TTD hemizygotes
T424	Noun_Phrase 11547 11556	XpdTTD/KO
T425	Noun_Phrase 11600 11618	cutaneous features
T426	Noun_Phrase 11645 11671	homozygous XpdTTD/TTD mice
T427	Noun_Phrase 11656 11666	XpdTTD/TTD
T428	Noun_Phrase 11673 11675	21
T429	Noun_Phrase 11707 11710	TTD
T430	Noun_Phrase 11707 11710	TTD
T431	Noun_Phrase 11761 11800	Compound Heterozygous XpdTTD/†XPCS Mice
T432	Noun_Phrase 11783 11795	XpdTTD/†XPCS
T433	Noun_Phrase 11803 11804	A
T434	Noun_Phrase 11841 11851	XpdTTD/TTD
T435	Noun_Phrase 11875 11887	XpdTTD/†XPCS
T436	Noun_Phrase 11893 11895	wt
T437	Noun_Phrase 11893 11900	wt mice
T438	IDENTITY_chain 11893 11900	wt mice
T439	Noun_Phrase 11945 11946	B
T440	IDENTITY_chain 11945 11946	B
T441	Noun_Phrase 11977 11984;11997 12009;12018 12022	skin of XpdTTD/†XPCS mice
T442	IDENTITY_chain 11977 11984;11997 12009;12018 12022	skin of XpdTTD/†XPCS mice
T443	Noun_Phrase 11985 11995;12018 12022	XpdTTD/TTD mice
T444	Noun_Phrase 11985 11995	XpdTTD/TTD
T445	Noun_Phrase 11997 12009	XpdTTD/†XPCS
T446	Noun_Phrase 11997 12009;12018 12022	XpdTTD/†XPCS mice
T447	Noun_Phrase 12015 12017	wt
T448	Noun_Phrase 12015 12022	wt mice
T449	Noun_Phrase 12254 12266	XpdTTD/†XPCS
T450	Noun_Phrase 12254 12266;12274 12278	XpdTTD/†XPCS mice
T451	Noun_Phrase 12271 12273	wt
T452	Noun_Phrase 12271 12278	wt mice
T453	Noun_Phrase 12302 12303	C
T454	Noun_Phrase 12305 12313	Cysteine
T455	Noun_Phrase 12335 12337	wt
T456	Noun_Phrase 12335 12337;12368 12372	wt mice
T457	Noun_Phrase 12339 12349	XpdTTD/TTD
T458	Noun_Phrase 12339 12349;12368 12372	XpdTTD/TTD mice
T459	Noun_Phrase 12355 12367	XpdTTD/†XPCS
T460	Noun_Phrase 12355 12372	XpdTTD/†XPCS mice
T461	Noun_Phrase 12428 12435	mutants
T462	Noun_Phrase 12440 12442	wt
T463	Noun_Phrase 12463 12473;12491 12495	XpdTTD/TTD mice
T464	Noun_Phrase 12463 12473	XpdTTD/TTD
T465	Noun_Phrase 12478 12490	XpdTTD/†XPCS
T466	Noun_Phrase 12478 12495	XpdTTD/†XPCS mice
T467	Noun_Phrase 12497 12502	Error
T468	IDENTITY_chain 12497 12502	Error
T469	Noun_Phrase 12497 12507	Error bars
T470	IDENTITY_chain 12497 12507	Error bars
T471	Noun_Phrase 12517 12543	standard error of the mean
T472	APPOS_relation 12517 12543	standard error of the mean
T473	IDENTITY_chain 12517 12543	standard error of the mean
T474	Noun_Phrase 12545 12548	SEM
T475	Noun_Phrase 12553 12554	D
T476	IDENTITY_chain 12553 12554	D
T477	Noun_Phrase 12588 12598	XpdTTD/TTD
T478	Noun_Phrase 12588 12598;12616 12620	XpdTTD/TTD mice
T479	Noun_Phrase 12603 12615	XpdTTD/†XPCS
T480	Noun_Phrase 12603 12620	XpdTTD/†XPCS mice
T481	Noun_Phrase 12691 12693	wt
T482	Noun_Phrase 12695 12700	Error
T483	Noun_Phrase 12695 12705	Error bars
T484	Noun_Phrase 12715 12718	SEM
T485	Noun_Phrase 12722 12723	E
T486	IDENTITY_chain 12722 12723	E
T487	Noun_Phrase 12752 12762	XpdTTD/TTD
T488	Noun_Phrase 12767 12779	XpdTTD/†XPCS
T489	Noun_Phrase 12860 12862	wt
T490	Noun_Phrase 12867 12879	heterozygote
T491	APPOS_relation 12867 12879	heterozygote
T492	Noun_Phrase 12881 12883	hz
T493	Noun_Phrase 12912 12917	Error
T494	Noun_Phrase 12912 12922	Error bars
T495	Noun_Phrase 12932 12935	SEM
T496	Noun_Phrase 12954 12957	TTD
T497	Noun_Phrase 12954 12957	TTD
T498	Noun_Phrase 12995 13005	acanthosis
T499	APPOS_relation 12995 13005	acanthosis
T500	Noun_Phrase 13007 13053	thickening of the layer of the nucleated cells
T501	Noun_Phrase 13056 13070	hyperkeratosis
T502	APPOS_relation 13056 13070	hyperkeratosis
T503	Noun_Phrase 13072 13115	prominent thickening of the cornified layer
T504	Noun_Phrase 13210 13218	the hair
T505	Noun_Phrase 13236 13265	the skin of XpdTTD/†XPCS mice
T506	Noun_Phrase 13248 13260	XpdTTD/†XPCS
T507	Noun_Phrase 13248 13265	XpdTTD/†XPCS mice
T508	Noun_Phrase 13318 13322	skin
T509	Noun_Phrase 13333 13342	Figure 2B
T510	Noun_Phrase 13415 13418	TTD
T511	Noun_Phrase 13420 13422	24
T512	IDENTITY_chain 13420 13422	24
T513	Noun_Phrase 13431 13441	XpdTTD/TTD
T514	Noun_Phrase 13431 13446	XpdTTD/TTD mice
T515	Noun_Phrase 13448 13450	15
T516	Noun_Phrase 13483 13522	compound heterozygous XpdTTD/†XPCS mice
T517	Noun_Phrase 13505 13517	XpdTTD/†XPCS
T518	Noun_Phrase 13524 13530;13538 13540	Figure 2E
T519	Noun_Phrase 13524 13533	Figure 2D
T520	Noun_Phrase 13576 13579	TTD
T521	Noun_Phrase 13588 13617	Homozygous Lethal Xpd Alleles
T522	Noun_Phrase 13641 13644	TTD
T523	Noun_Phrase 13646 13650	XPCS
T524	Noun_Phrase 13656 13658	CS
T525	Noun_Phrase 13668 13670	XP
T526	Noun_Phrase 13694 13699	mouse
T527	Noun_Phrase 13753 13755	12
T528	Noun_Phrase 13756 13758	13
T529	Noun_Phrase 13759 13761	15
T530	Noun_Phrase 13762 13764	23
T531	Noun_Phrase 13767 13769	we
T532	Noun_Phrase 13814 13840	compound heterozygous mice
T533	Noun_Phrase 13842 13850	Figure 3
T534	IDENTITY_chain 13842 13850	Figure 3
T535	Noun_Phrase 13861 13871	XpdTTD/TTD
T536	Noun_Phrase 13861 13879	XpdTTD/TTD animals
T537	Noun_Phrase 13988 13990	15
T538	Noun_Phrase 14013 14052	compound heterozygous XpdTTD/†XPCS mice
T539	Noun_Phrase 14035 14047	XpdTTD/†XPCS
T540	Noun_Phrase 14072 14074	wt
T541	Noun_Phrase 14083 14095	20 mo of age
T542	IDENTITY_chain 14083 14095	20 mo of age
T543	Noun_Phrase 14097 14103;14111 14113	Figure 3C
T544	IDENTITY_chain 14097 14103;14111 14113	Figure 3C
T545	Noun_Phrase 14097 14106	Figure 3B
T546	IDENTITY_chain 14097 14106	Figure 3B
T547	Noun_Phrase 14137 14147	XpdTTD/TTD
T548	Noun_Phrase 14137 14152	XpdTTD/TTD mice
T549	Noun_Phrase 14185 14187	wt
T550	Noun_Phrase 14219 14224	20 mo
T551	Noun_Phrase 14227 14266	compound heterozygous XpdTTD/†XPCS mice
T552	Noun_Phrase 14249 14261	XpdTTD/†XPCS
T553	Noun_Phrase 14276 14285	Figure 3B
T554	Noun_Phrase 14440 14479	compound heterozygous XpdTTD/†XPCS mice
T555	Noun_Phrase 14462 14474	XpdTTD/†XPCS
T556	Noun_Phrase 14481 14487;14495 14497	Figure 3D
T557	IDENTITY_chain 14481 14487;14495 14497	Figure 3D
T558	Noun_Phrase 14481 14490	Figure 3A
T559	IDENTITY_chain 14481 14490	Figure 3A
T560	Noun_Phrase 14526 14548	compound heterozygotes
T561	Noun_Phrase 14574 14584	XpdTTD/TTD
T562	Noun_Phrase 14574 14589	XpdTTD/TTD mice
T563	Noun_Phrase 14591 14598	Table 2
T564	IDENTITY_chain 14591 14598	Table 2
T565	Noun_Phrase 14602 14610	Figure 3
T566	Noun_Phrase 14669 14709	Compound Heterozygous Xpd TTD/†XPCS Mice
T567	Noun_Phrase 14691 14704	Xpd TTD/†XPCS
T568	Noun_Phrase 14712 14713	A
T569	Noun_Phrase 14730 14739	20-mo-old
T570	Noun_Phrase 14740 14742	wt
T571	Noun_Phrase 14766 14778	XpdTTD/†XPCS
T572	Noun_Phrase 14795 14805	XpdTTD/TTD
T573	Noun_Phrase 14829 14837	cachexia
T574	APPOS_relation 14829 14837	cachexia
T575	IDENTITY_chain 14829 14837	cachexia
T576	Noun_Phrase 14839 14863	lack of subcutaneous fat
T577	Noun_Phrase 14872 14882	XpdTTD/TTD
T578	Noun_Phrase 14872 14888	XpdTTD/TTD mouse
T579	Noun_Phrase 14908 14922	this phenotype
T580	Noun_Phrase 14926 14928	wt
T581	Noun_Phrase 14926 14928;14946 14950	wt mice
T582	Noun_Phrase 14933 14945	XpdTTD/†XPCS
T583	Noun_Phrase 14933 14950	XpdTTD/†XPCS mice
T584	Noun_Phrase 14954 14955	B
T585	Noun_Phrase 14972 14981	20-mo-old
T586	Noun_Phrase 14972 14986;14991 15003;15020 15024	20-mo-old male XpdTTD/†XPCS mice
T587	IDENTITY_chain 14972 14986;14991 15003;15020 15024	20-mo-old male XpdTTD/†XPCS mice
T588	IDENTITY_chain 14972 14986;15009 15019	20-mo-old male XpdTTD/TTD
T589	Noun_Phrase 14972 14986;15009 15024	20-mo-old male XpdTTD/TTD mice
T590	IDENTITY_chain 14972 14986;15009 15024	20-mo-old male XpdTTD/TTD mice
T591	Noun_Phrase 14972 14989;15020 15024	20-mo-old male wt mice
T592	IDENTITY_chain 14972 14989;15020 15024	20-mo-old male wt mice
T593	Noun_Phrase 14982 14986	male
T594	IDENTITY_chain 14982 14986	male
T595	Noun_Phrase 14987 14989	wt
T596	Noun_Phrase 14991 15003	XpdTTD/†XPCS
T597	Noun_Phrase 15009 15019	XpdTTD/TTD
T598	Noun_Phrase 15033 15043	XpdTTD/TTD
T599	Noun_Phrase 15057 15065	kyphosis
T600	APPOS_relation 15057 15065	kyphosis
T601	Noun_Phrase 15057 15210	kyphosis (curvature of the spinal column) and reduction of bone mineral density as shown in the 6–8 segment of the tail vertebrae counted from the pelvis
T602	IDENTITY_chain 15057 15210	kyphosis (curvature of the spinal column) and reduction of bone mineral density as shown in the 6–8 segment of the tail vertebrae counted from the pelvis
T603	Noun_Phrase 15067 15097	curvature of the spinal column
T604	Noun_Phrase 15116 15136	bone mineral density
T605	Noun_Phrase 15256 15270	these features
T606	Noun_Phrase 15274 15299	the XpdTTD / † XPCS mouse
T607	Noun_Phrase 15278 15293	XpdTTD / † XPCS
T608	Noun_Phrase 15303 15304	C
T609	Noun_Phrase 15377 15386	20-mo-old
T610	Noun_Phrase 15377 15391;15404 15416;15449 15453	20-mo-old male XpdTTD/†XPCS mice
T611	Noun_Phrase 15377 15391;15430 15453	20-mo-old male XpdTTD/TTD (n = 3) mice
T612	Noun_Phrase 15377 15394;15449 15453	20-mo-old male wt mice
T613	Noun_Phrase 15387 15391	male
T614	Noun_Phrase 15392 15394	wt
T615	Noun_Phrase 15404 15416	XpdTTD/†XPCS
T616	Noun_Phrase 15430 15440	XpdTTD/TTD
T617	Noun_Phrase 15524 15534	XpdTTD/TTD
T618	Noun_Phrase 15536 15541	Error
T619	Noun_Phrase 15536 15546	Error bars
T620	Noun_Phrase 15556 15559	SEM
T621	Noun_Phrase 15563 15564	D
T622	Noun_Phrase 15657 15667	XpdTTD/TTD
T623	Noun_Phrase 15657 15672	XpdTTD/TTD mice
T624	Noun_Phrase 15688 15728	both male and female XpdTTD / †XPCS mice
T625	Noun_Phrase 15693 15697	male
T626	Noun_Phrase 15702 15708	female
T627	Noun_Phrase 15762 15764	wt
T628	Noun_Phrase 15769 15779;15816 15820	XpdTTD/TTD mice
T629	Noun_Phrase 15769 15779	XpdTTD/TTD
T630	Noun_Phrase 15796 15798	wt
T631	Noun_Phrase 15796 15798;15816 15820	wt mice
T632	Noun_Phrase 15803 15815	XpdTTD/†XPCS
T633	Noun_Phrase 15803 15820	XpdTTD/†XPCS mice
T634	Noun_Phrase 15884 15889	Error
T635	Noun_Phrase 15884 15894	Error bars
T636	Noun_Phrase 15904 15907	SEM
T637	Noun_Phrase 15910 15917	Table 2
T638	Noun_Phrase 15956 15960	Mice
T639	Noun_Phrase 15993 16030	the homozygous lethal Xpd†XPCS allele
T640	Noun_Phrase 16015 16023	Xpd†XPCS
T641	Noun_Phrase 16045 16048	its
T642	Noun_Phrase 16096 16113	the XpdTTD allele
T643	Noun_Phrase 16100 16106	XpdTTD
T644	Noun_Phrase 16115 16117	we
T645	Noun_Phrase 16150 16160	XpdTTD/†XP
T646	IDENTITY_chain 16150 16160	XpdTTD/†XP
T647	Noun_Phrase 16233 16242	Xpd †XPCS
T648	Noun_Phrase 16251 16652	the homozygous lethal Xpd †XP allele rescued cutaneous symptoms including hair loss (except locally during the first round; unpublished data), reduced cysteine content (cysteine index 9.3 ± 0.9 standard deviation [87% of wt], p = 0.01 versus TTD), ageing-associated premature cachexia (males and females were 36.1 ± 6.4 g [93% of wt] and 39.2 ± 3.2 g [116% of wt], respectively), and reduced life span
T649	IDENTITY_chain 16251 16652	the homozygous lethal Xpd †XP allele rescued cutaneous symptoms including hair loss (except locally during the first round; unpublished data), reduced cysteine content (cysteine index 9.3 ± 0.9 standard deviation [87% of wt], p = 0.01 versus TTD), ageing-associated premature cachexia (males and females were 36.1 ± 6.4 g [93% of wt] and 39.2 ± 3.2 g [116% of wt], respectively), and reduced life span
T650	Noun_Phrase 16273 16280	Xpd †XP
T651	IDENTITY_chain 16273 16280	Xpd †XP
T652	Noun_Phrase 16325 16329	hair
T653	Noun_Phrase 16375 16391	unpublished data
T654	Noun_Phrase 16402 16410	cysteine
T655	Noun_Phrase 16420 16428	cysteine
T656	Noun_Phrase 16472 16474	wt
T657	Noun_Phrase 16493 16496	TTD
T658	Noun_Phrase 16493 16496	TTD
T659	Noun_Phrase 16537 16542	males
T660	Noun_Phrase 16547 16554	females
T661	Noun_Phrase 16581 16583	wt
T662	Noun_Phrase 16611 16613	wt
T663	Noun_Phrase 16654 16661	Table 2
T664	Noun_Phrase 16680 16690	these data
T665	Noun_Phrase 16705 16780	two independent alleles, which on their own are unable to support viability
T666	IDENTITY_chain 16705 16780	two independent alleles, which on their own are unable to support viability
T667	Noun_Phrase 16739 16744	their
T668	Noun_Phrase 16782 16789	Table 1
T669	Noun_Phrase 16863 16870	Table 2
T670	Noun_Phrase 16898 16915	Biallelic Effects
T671	Noun_Phrase 16917 16919	We
T672	Noun_Phrase 16935 16959	UV-based cellular assays
T673	IDENTITY_chain 16935 16959	UV-based cellular assays
T674	Noun_Phrase 16970 17016	unscheduled DNA synthesis after UV irradiation
T675	APPOS_relation 16970 17016	unscheduled DNA synthesis after UV irradiation
T676	IDENTITY_chain 16970 17016	unscheduled DNA synthesis after UV irradiation
T677	Noun_Phrase 16970 17099	unscheduled DNA synthesis after UV irradiation (UV-UDS), recovery of RNA synthesis after UV irradiation (UV-RRS), and UV survival
T678	IDENTITY_chain 16970 17099	unscheduled DNA synthesis after UV irradiation (UV-UDS), recovery of RNA synthesis after UV irradiation (UV-RRS), and UV survival
T679	Noun_Phrase 17002 17004	UV
T680	Noun_Phrase 17002 17016	UV irradiation
T681	IDENTITY_chain 17002 17016	UV irradiation
T682	Noun_Phrase 17018 17024	UV-UDS
T683	Noun_Phrase 17027 17073	recovery of RNA synthesis after UV irradiation
T684	APPOS_relation 17027 17073	recovery of RNA synthesis after UV irradiation
T685	IDENTITY_chain 17027 17073	recovery of RNA synthesis after UV irradiation
T686	Noun_Phrase 17059 17061	UV
T687	Noun_Phrase 17059 17073	UV irradiation
T688	Noun_Phrase 17075 17081	UV-RRS
T689	Noun_Phrase 17088 17090	UV
T690	Noun_Phrase 17088 17099	UV survival
T691	Noun_Phrase 17117 17136	the NER subpathways
T692	Noun_Phrase 17121 17124	NER
T693	Noun_Phrase 17138 17185	global genome NER and transcription-coupled NER
T694	APPOS_relation 17138 17185	global genome NER and transcription-coupled NER
T695	IDENTITY_chain 17138 17185	global genome NER and transcription-coupled NER
T696	Noun_Phrase 17219 18954	none of these assays was the response to UV improved in compound heterozygotes relative to TTD homozygotes (Figure 4A–4C). However, unlike the in vivo TTD phenotypes described above, in which XpdTTD/TTD and XpdTTD/KO animals were indistinguishable, XpdTTD dosage effects were observed in UV survival, UV-UDS, and UV-RRS, indicating that cellular parameters as measured in fibroblasts here do not always correlate with the phenotype at the level of the intact organism. XpdTTD/KO hemizygous cells were thus used as the baseline on which to compare the activity of compound heterozygous cells. Relative to XpdTTD/KO hemizygote cells, UV survival was improved by the homozygous lethal Xpd†XPCS allele in XpdTTD/†XPCS compound heterozygous cells and to a lesser degree by the Xpd†XP allele (Figure 4A). Because of embryonic and cellular lethality, we were unable to test UV survival associated exclusively with the Xpd†XPCS or Xpd†XP alleles. However, homozygous XPDXP (XPDR683W) and hemizygous XPDXPCS (XPDG602D) human cells are known to be highly sensitive to UV [19,25], as are cells from a homozygous viable XpdXPCS/XPCS (XPDG602D/G602D) mouse model (Figure 4A, dotted line) [23]. Thus, the survival of XpdTTD/†XPCS (and XpdTTD/†XP) cells likely represents a level of UV resistance that neither mutant allele can impart on its own (Table 2). Significant effects of compound heterozygosity on NER subpathways relative to XpdTTD/KO cells were observed in XpdTTD/†XP cells but only for UV-UDS activity. Finally, none of the mutant TFIIH combinations (carrying alterations associated with TTD [XPDR722W], XPCS [XPDG602D], or XP [XPDR683W]) exhibited synergism in an in vitro NER reaction reconstituted with different mutant TFIIH complexes
T697	IDENTITY_chain 17219 18954	none of these assays was the response to UV improved in compound heterozygotes relative to TTD homozygotes (Figure 4A–4C). However, unlike the in vivo TTD phenotypes described above, in which XpdTTD/TTD and XpdTTD/KO animals were indistinguishable, XpdTTD dosage effects were observed in UV survival, UV-UDS, and UV-RRS, indicating that cellular parameters as measured in fibroblasts here do not always correlate with the phenotype at the level of the intact organism. XpdTTD/KO hemizygous cells were thus used as the baseline on which to compare the activity of compound heterozygous cells. Relative to XpdTTD/KO hemizygote cells, UV survival was improved by the homozygous lethal Xpd†XPCS allele in XpdTTD/†XPCS compound heterozygous cells and to a lesser degree by the Xpd†XP allele (Figure 4A). Because of embryonic and cellular lethality, we were unable to test UV survival associated exclusively with the Xpd†XPCS or Xpd†XP alleles. However, homozygous XPDXP (XPDR683W) and hemizygous XPDXPCS (XPDG602D) human cells are known to be highly sensitive to UV [19,25], as are cells from a homozygous viable XpdXPCS/XPCS (XPDG602D/G602D) mouse model (Figure 4A, dotted line) [23]. Thus, the survival of XpdTTD/†XPCS (and XpdTTD/†XP) cells likely represents a level of UV resistance that neither mutant allele can impart on its own (Table 2). Significant effects of compound heterozygosity on NER subpathways relative to XpdTTD/KO cells were observed in XpdTTD/†XP cells but only for UV-UDS activity. Finally, none of the mutant TFIIH combinations (carrying alterations associated with TTD [XPDR722W], XPCS [XPDG602D], or XP [XPDR683W]) exhibited synergism in an in vitro NER reaction reconstituted with different mutant TFIIH complexes
T698	Noun_Phrase 17227 17239	these assays
T699	Noun_Phrase 17260 17262	UV
T700	Noun_Phrase 17275 17297	compound heterozygotes
T701	Noun_Phrase 17310 17313	TTD
T702	Noun_Phrase 17327 17333;17337 17339	Figure 4C
T703	IDENTITY_chain 17327 17333;17337 17339	Figure 4C
T704	Noun_Phrase 17327 17336	Figure 4A
T705	IDENTITY_chain 17327 17336	Figure 4A
T706	Noun_Phrase 17370 17373	TTD
T707	Noun_Phrase 17411 17421	XpdTTD/TTD
T708	Noun_Phrase 17411 17421;17436 17443	XpdTTD/TTD animals
T709	Noun_Phrase 17426 17435	XpdTTD/KO
T710	Noun_Phrase 17468 17474	XpdTTD
T711	Noun_Phrase 17507 17509	UV
T712	Noun_Phrase 17507 17518	UV survival
T713	Noun_Phrase 17507 17538	UV survival, UV-UDS, and UV-RRS
T714	Noun_Phrase 17520 17526	UV-UDS
T715	Noun_Phrase 17532 17538	UV-RRS
T716	Noun_Phrase 17688 17697	XpdTTD/KO
T717	Noun_Phrase 17688 17714	XpdTTD/KO hemizygous cells
T718	IDENTITY_chain 17688 17714	XpdTTD/KO hemizygous cells
T719	Noun_Phrase 17823 17832	XpdTTD/KO
T720	Noun_Phrase 17823 17849	XpdTTD/KO hemizygote cells
T721	Noun_Phrase 17851 17853	UV
T722	Noun_Phrase 17851 17862	UV survival
T723	Noun_Phrase 17901 17909	Xpd†XPCS
T724	Noun_Phrase 17920 17932	XpdTTD/†XPCS
T725	Noun_Phrase 17987 18004	the Xpd†XP allele
T726	IDENTITY_chain 17987 18004	the Xpd†XP allele
T727	Noun_Phrase 17991 17997	Xpd†XP
T728	Noun_Phrase 18006 18015	Figure 4A
T729	Noun_Phrase 18029 18038;18052 18061	embryonic lethality
T730	IDENTITY_chain 18029 18038;18052 18061	embryonic lethality
T731	Noun_Phrase 18063 18065	we
T732	Noun_Phrase 18086 18088	UV
T733	Noun_Phrase 18126 18129;18142 18156	the Xpd†XP alleles
T734	Noun_Phrase 18126 18138;18149 18156	the Xpd†XPCS alleles
T735	Noun_Phrase 18130 18138	Xpd†XPCS
T736	Noun_Phrase 18142 18148	Xpd†XP
T737	Noun_Phrase 18167 18183	homozygous XPDXP
T738	APPOS_relation 18167 18183	homozygous XPDXP
T739	Noun_Phrase 18185 18193	XPDR683W
T740	Noun_Phrase 18199 18217	hemizygous XPDXPCS
T741	APPOS_relation 18199 18217	hemizygous XPDXPCS
T742	Noun_Phrase 18219 18227	XPDG602D
T743	Noun_Phrase 18229 18234	human
T744	Noun_Phrase 18277 18279	UV
T745	Noun_Phrase 18281 18283	19
T746	Noun_Phrase 18309 18339	homozygous viable XpdXPCS/XPCS
T747	Noun_Phrase 18327 18339	XpdXPCS/XPCS
T748	APPOS_relation 18341 18355	XPDG602D/G602D
T749	Noun_Phrase 18341 18355	XPDG602D/G602D
T750	Noun_Phrase 18357 18362	mouse
T751	Noun_Phrase 18370 18379	Figure 4A
T752	Noun_Phrase 18395 18397	23
T753	Noun_Phrase 18422 18434	XpdTTD/†XPCS
T754	Noun_Phrase 18422 18450	XpdTTD/†XPCS (and XpdTTD/†XP
T755	IDENTITY_chain 18422 18450	XpdTTD/†XPCS (and XpdTTD/†XP
T756	Noun_Phrase 18487 18489	UV
T757	Noun_Phrase 18514 18520	mutant
T758	Noun_Phrase 18551 18558	Table 2
T759	Noun_Phrase 18584 18607	compound heterozygosity
T760	Noun_Phrase 18611 18614	NER
T761	Noun_Phrase 18611 18626	NER subpathways
T762	Noun_Phrase 18639 18648	XpdTTD/KO
T763	Noun_Phrase 18672 18682	XpdTTD/†XP
T764	Noun_Phrase 18672 18688	XpdTTD/†XP cells
T765	IDENTITY_chain 18672 18688	XpdTTD/†XP cells
T766	Noun_Phrase 18702 18708	UV-UDS
T767	Noun_Phrase 18736 18803;18820 18824	the mutant TFIIH combinations (carrying alterations associated with XPCS
T768	Noun_Phrase 18736 18803;18840 18842	the mutant TFIIH combinations (carrying alterations associated with XP
T769	APPOS_relation 18736 18803;18840 18842	the mutant TFIIH combinations (carrying alterations associated with XP
T770	Noun_Phrase 18736 18807	the mutant TFIIH combinations (carrying alterations associated with TTD
T771	Noun_Phrase 18740 18746	mutant
T772	Noun_Phrase 18740 18752	mutant TFIIH
T773	IDENTITY_chain 18740 18752	mutant TFIIH
T774	Noun_Phrase 18804 18807	TTD
T775	APPOS_relation 18809 18817	XPDR722W
T776	Noun_Phrase 18809 18817	XPDR722W
T777	Noun_Phrase 18820 18824	XPCS
T778	APPOS_relation 18826 18834	XPDG602D
T779	Noun_Phrase 18826 18834	XPDG602D
T780	Noun_Phrase 18840 18842	XP
T781	Noun_Phrase 18844 18852	XPDR683W
T782	Noun_Phrase 18890 18893	NER
T783	Noun_Phrase 18932 18938	mutant
T784	Noun_Phrase 18932 18944	mutant TFIIH
T785	Noun_Phrase 18956 18965	Figure 4D
T786	IDENTITY_chain 18956 18965	Figure 4D
T787	Noun_Phrase 18984 18994	these data
T788	Noun_Phrase 19047 19049	UV
T789	Noun_Phrase 19160 19163	TTD
T790	Noun_Phrase 19214 19219	TFIIH
T791	Noun_Phrase 19284 19285	A
T792	Noun_Phrase 19311 19313	UV
T793	Noun_Phrase 19311 19325	UV irradiation
T794	Noun_Phrase 19337 19357	hemizygous XpdTTD/KO
T795	IDENTITY_chain 19337 19357	hemizygous XpdTTD/KO
T796	Noun_Phrase 19370 19378;19390 19397	Xpd†XPCS alleles
T797	Noun_Phrase 19370 19378	Xpd†XPCS
T798	Noun_Phrase 19370 19397	Xpd†XPCS and Xpd†XP alleles
T799	IDENTITY_chain 19370 19397	Xpd†XPCS and Xpd†XP alleles
T800	Noun_Phrase 19383 19389	Xpd†XP
T801	Noun_Phrase 19383 19397	Xpd†XP alleles
T802	Noun_Phrase 19453 19455	UV
T803	Noun_Phrase 19468 19491	homozygous XpdXPCS/XPCS
T804	Noun_Phrase 19552 19559	XpdXPCS
T805	Noun_Phrase 19723 19728	Error
T806	Noun_Phrase 19723 19733	Error bars
T807	Noun_Phrase 19773 19779	UV-UDS
T808	APPOS_relation 19773 19779	UV-UDS
T809	Noun_Phrase 19781 19814	a measure of global genome repair
T810	Noun_Phrase 19847 19857	XpdTTD/TTD
T811	Noun_Phrase 19867 19876	XpdTTD/KO
T812	Noun_Phrase 19886 19898	XpdTTD/†XPCS
T813	Noun_Phrase 19908 19918	XpdTTD/†XP
T814	Noun_Phrase 20034 20044	XpdTTD/TTD
T815	Noun_Phrase 20092 20101	XpdTTD/KO
T816	Noun_Phrase 20105 20106	C
T817	Noun_Phrase 20108 20114	UV-RRS
T818	APPOS_relation 20108 20114	UV-RRS
T819	Noun_Phrase 20116 20179	a measure of transcription-coupled repair of UV-induced lesions
T820	Noun_Phrase 20211 20221	XpdTTD/TTD
T821	Noun_Phrase 20231 20240	XpdTTD/KO
T822	Noun_Phrase 20250 20262	XpdTTD/†XPCS
T823	Noun_Phrase 20272 20282	XpdTTD/†XP
T824	Noun_Phrase 20349 20350	D
T825	Noun_Phrase 20406 20411	TFIIH
T826	Noun_Phrase 20503 20521	recombinant TFIIHs
T827	IDENTITY_chain 20503 20521	recombinant TFIIHs
T828	Noun_Phrase 20534 20537	XPD
T829	Noun_Phrase 20539 20542	XPB
T830	IDENTITY_chain 20539 20542	XPB
T831	Noun_Phrase 20544 20547	p62
T832	IDENTITY_chain 20544 20547	p62
T833	Noun_Phrase 20917 20922	TFIIH
T834	Noun_Phrase 20959 20961	wt
T835	Noun_Phrase 21005 21006	E
T836	IDENTITY_chain 21005 21006	E
T837	Noun_Phrase 21040 21045	TFIIH
T838	Noun_Phrase 21060 21070	XpdTTD/TTD
T839	Noun_Phrase 21072 21092	hemizygous XpdTTD/KO
T840	Noun_Phrase 21120 21132	XpdTTD/†XPCS
T841	Noun_Phrase 21137 21147	XpdTTD/†XP
T842	Noun_Phrase 21137 21153	XpdTTD/†XP cells
T843	Noun_Phrase 21195 21215	p62 subunit of TFIIH
T844	Noun_Phrase 21210 21215	TFIIH
T845	Noun_Phrase 21337 21339	wt
T846	Noun_Phrase 21376 21386	XpdTTD/TTD
T847	Noun_Phrase 21421 21430	XpdTTD/KO
T848	Noun_Phrase 21461 21463	wt
T849	Noun_Phrase 21506 21518	XpdTTD/†XPCS
T850	Noun_Phrase 21554 21556	wt
T851	Noun_Phrase 21599 21609	XpdTTD/†XP
T852	Noun_Phrase 21637 21638	F
T853	IDENTITY_chain 21637 21638	F
T854	Noun_Phrase 21850 21852	wt
T855	Noun_Phrase 21927 21929	wt
T856	Noun_Phrase 22027 22029	we
T857	Noun_Phrase 22044 22056;22068 22075	the Xpd†XPCS alleles
T858	Noun_Phrase 22044 22075	the Xpd†XPCS and Xpd†XP alleles
T859	Noun_Phrase 22048 22056	Xpd†XPCS
T860	Noun_Phrase 22061 22067	Xpd†XP
T861	Noun_Phrase 22061 22075	Xpd†XP alleles
T862	Noun_Phrase 22095 22099	mRNA
T863	Noun_Phrase 22095 22099	mRNA
T864	Noun_Phrase 22120 22132	TTD symptoms
T865	IDENTITY_chain 22120 22132	TTD symptoms
T866	Noun_Phrase 22155 22160	TFIIH
T867	Noun_Phrase 22171 22206	compound heterozygous XpdTTD/ †XPCS
T868	IDENTITY_chain 22171 22206	compound heterozygous XpdTTD/ †XPCS
T869	Noun_Phrase 22282 22284	we
T870	Noun_Phrase 22333 22338	TFIIH
T871	Noun_Phrase 22388 22391	TTD
T872	Noun_Phrase 22406 22408	wt
T873	Noun_Phrase 22444 22446	16
T874	Noun_Phrase 22447 22449	17
T875	Noun_Phrase 22488 22505	the XpdTTD allele
T876	Noun_Phrase 22492 22498	XpdTTD
T877	Noun_Phrase 22522 22524	wt
T878	Noun_Phrase 22522 22531	wt allele
T879	Noun_Phrase 22533 22542	Figure 1E
T880	Noun_Phrase 22545 22550	TFIIH
T881	Noun_Phrase 22597 22602	mouse
T882	Noun_Phrase 22603 22613	XpdTTD/TTD
T883	Noun_Phrase 22627 22633;22641 22643	Figure 4F
T884	Noun_Phrase 22627 22636	Figure 4E
T885	Noun_Phrase 22681 22686	human
T886	Noun_Phrase 22701 22704	TTD
T887	Noun_Phrase 22782 22784	wt
T888	Noun_Phrase 22782 22790	wt level
T889	Noun_Phrase 22807 22827	hemizygous XpdTTD/KO
T890	Noun_Phrase 22855 22859	mRNA
T891	Noun_Phrase 22887 22899;22915 22921	the Xpd†XPCS allele
T892	Noun_Phrase 22891 22899	Xpd†XPCS
T893	Noun_Phrase 22904 22921	the Xpd†XP allele
T894	Noun_Phrase 22908 22914	Xpd†XP
T895	Noun_Phrase 22942 22947	TFIIH
T896	Noun_Phrase 22961 22963	wt
T897	Noun_Phrase 22961 22970	wt levels
T898	Noun_Phrase 22974 22980	XpdTTD
T899	Noun_Phrase 23010 23016;23024 23026	Figure 4F
T900	Noun_Phrase 23010 23019	Figure 4E
T901	Noun_Phrase 23048 23050	UV
T902	Noun_Phrase 23072 23093	compound heterozygote
T903	Noun_Phrase 23101 23110	Figure 4A
T904	Noun_Phrase 23137 23140	TTD
T905	Noun_Phrase 23161 23169	Figure 3
T906	Noun_Phrase 23204 23209	TFIIH
T907	Noun_Phrase 23280 23304	these phenotypes in vivo
T908	Noun_Phrase 23333 23337	XPCS
T909	Noun_Phrase 23338 23342	mRNA
T910	Noun_Phrase 23380 23399	the encoded protein
T911	Noun_Phrase 23401 23409	XPDG602D
T912	APPOS_relation 23401 23409	XPDG602D
T913	Noun_Phrase 23426 23429	TTD
T914	Noun_Phrase 23465 23478	XpdTTD/ †XPCS
T915	IDENTITY_chain 23465 23478	XpdTTD/ †XPCS
T916	Noun_Phrase 23501 23504	TTD
T917	Noun_Phrase 23552 23560	Xpd†XPCS
T918	Noun_Phrase 23581 23592	XpdTTD/XPCS
T919	IDENTITY_chain 23581 23592	XpdTTD/XPCS
T920	Noun_Phrase 23605 23607	wt
T921	Noun_Phrase 23672 23679	XpdXPCS
T922	Noun_Phrase 23688 23695	Table 2
T923	Noun_Phrase 23700 23716	unpublished data
T924	Noun_Phrase 23761 23785	these two mutant alleles
T925	Noun_Phrase 23771 23777	mutant
T926	Noun_Phrase 23795 23800	their
T927	Noun_Phrase 23840 23844	hair
T928	Noun_Phrase 23912 23922	phenotypes
T929	IDENTITY_chain 23912 23922	phenotypes
T930	Noun_Phrase 23952 23957	TFIIH
T931	Noun_Phrase 23970 23974	mice
T932	Noun_Phrase 24001 24008	Table 2
T933	Noun_Phrase 24082 24091	Phenotype
T934	Noun_Phrase 24102 24125	phenotypic consequences
T935	Noun_Phrase 24147 24164	biallelic effects
T936	Noun_Phrase 24195 24201	mutant
T937	Noun_Phrase 24213 24234	compound heterozygote
T938	Noun_Phrase 24266 24278	such effects
T939	Noun_Phrase 24349 24360	environment
T940	Noun_Phrase 24349 24383	environment and genetic background
T941	Noun_Phrase 24365 24383	genetic background
T942	Noun_Phrase 24385 24387	We
T943	Noun_Phrase 24665 24738	the allele associated in a homozygous state with a phenotype closer to wt
T944	IDENTITY_chain 24665 24738	the allele associated in a homozygous state with a phenotype closer to wt
T945	Noun_Phrase 24665 24783	the allele associated in a homozygous state with a phenotype closer to wt singularly determined the phenotypic outcome
T946	IDENTITY_chain 24665 24783	the allele associated in a homozygous state with a phenotype closer to wt singularly determined the phenotypic outcome
T947	Noun_Phrase 24736 24738	wt
T948	Noun_Phrase 24814 24819	human
T949	Noun_Phrase 24814 24837	human recessive disease
T950	Noun_Phrase 24847 24864	these Xpd alleles
T951	Noun_Phrase 24887 24889	wt
T952	Noun_Phrase 24887 24896	wt levels
T953	Noun_Phrase 24936 24938	we
T954	Noun_Phrase 24944 24957	these effects
T955	Noun_Phrase 24970 24982	Such alleles
T956	Noun_Phrase 25052 25056	they
T957	Noun_Phrase 25242 25248	humans
T958	Noun_Phrase 25501 25508	Table 2
T959	Noun_Phrase 25560 25588	interallelic complementation
T960	Noun_Phrase 25594 25600	mutant
T961	Noun_Phrase 25640 25642	wt
T962	Noun_Phrase 25716 25723	Table 2
T963	Noun_Phrase 25750 25767	biallelic effects
T964	Noun_Phrase 25924 25927	XPD
T965	Noun_Phrase 25948 25950	We
T966	Noun_Phrase 25990 25996	XpdTTD
T967	Noun_Phrase 26004 26021;26035 26041	homozygous lethal Xpd†XP
T968	Noun_Phrase 26004 26030;26042 26049	homozygous lethal Xpd†XPCS alleles
T969	Noun_Phrase 26022 26030	Xpd†XPCS
T970	Noun_Phrase 26152 26171	embryonic lethality
T971	Noun_Phrase 26216 26220	skin
T972	Noun_Phrase 26225 26230	blood
T973	IDENTITY_chain 26225 26230	blood
T974	Noun_Phrase 26293 26296;26304 26312;26325 26332	the Xpd†XPCS alleles
T975	Noun_Phrase 26293 26296;26318 26332	the Xpd†XP alleles
T976	Noun_Phrase 26293 26332	the XpdKO, Xpd†XPCS, and Xpd†XP alleles
T977	IDENTITY_chain 26293 26332	the XpdKO, Xpd†XPCS, and Xpd†XP alleles
T978	Noun_Phrase 26297 26302	XpdKO
T979	IDENTITY_chain 26297 26302	XpdKO
T980	Noun_Phrase 26304 26312	Xpd†XPCS
T981	Noun_Phrase 26318 26324	Xpd†XP
T982	Noun_Phrase 26366 26385	basal transcription
T983	Noun_Phrase 26421 26434;26451 26472	XpdTTD/ †XPCS compound heterozygous
T984	Noun_Phrase 26479 26498	embryonic lethality
T985	Noun_Phrase 26520 26537	the XpdTTD allele
T986	Noun_Phrase 26524 26530	XpdTTD
T987	Noun_Phrase 26547 26566	embryonic lethality
T988	Noun_Phrase 26593 26602	XpdTTD/KO
T989	Noun_Phrase 26620 26637	the XpdTTD allele
T990	Noun_Phrase 26624 26630	XpdTTD
T991	Noun_Phrase 26659 26661	wt
T992	Noun_Phrase 26691 26720	the homozygous lethal alleles
T993	Noun_Phrase 26722 26727	XpdKO
T994	Noun_Phrase 26722 26749	XpdKO, Xpd†XPCS, and Xpd†XP
T995	APPOS_relation 26722 26749	XpdKO, Xpd†XPCS, and Xpd†XP
T996	Noun_Phrase 26729 26737	Xpd†XPCS
T997	Noun_Phrase 26743 26749	Xpd†XP
T998	Noun_Phrase 26767 26792	this particular phenotype
T999	Noun_Phrase 26794 26801	Table 2
T1000	Noun_Phrase 26805 26848	TTD-specific cutaneous and anaemic features
T1001	IDENTITY_chain 26805 26848	TTD-specific cutaneous and anaemic features
T1002	Noun_Phrase 27022 27026	skin
T1003	Noun_Phrase 27028 27038	hair-shaft
T1004	IDENTITY_chain 27028 27038	hair-shaft
T1005	Noun_Phrase 27044 27049	blood
T1006	Noun_Phrase 27057 27059	16
T1007	Noun_Phrase 27060 27062	24
T1008	Noun_Phrase 27068 27094	compound heterozygous mice
T1009	Noun_Phrase 27101 27118;27132 27138	homozygous lethal Xpd†XP
T1010	Noun_Phrase 27101 27127;27139 27146	homozygous lethal Xpd†XPCS alleles
T1011	Noun_Phrase 27119 27127	Xpd†XPCS
T1012	Noun_Phrase 27258 27275	the XpdTTD allele
T1013	Noun_Phrase 27262 27268	XpdTTD
T1014	Noun_Phrase 27292 27308	these phenotypes
T1015	Noun_Phrase 27310 27312	We
T1016	Noun_Phrase 27350 27369	embryonic lethality
T1017	Noun_Phrase 27415 27419	skin
T1018	Noun_Phrase 27421 27425	hair
T1019	Noun_Phrase 27431 27436	blood
T1020	Noun_Phrase 27563 27569	XpdTTD
T1021	Noun_Phrase 27587 27600;27611 27618	the Xpd†XPCS  alleles
T1022	Noun_Phrase 27591 27599	Xpd†XPCS
T1023	Noun_Phrase 27604 27610	Xpd†XP
T1024	Noun_Phrase 27604 27618	Xpd†XP alleles
T1025	Noun_Phrase 27656 27660	skin
T1026	Noun_Phrase 27662 27672	hair-shaft
T1027	Noun_Phrase 27678 27683	blood
T1028	Noun_Phrase 27722 27725	its
T1029	Noun_Phrase 27748 27750	UV
T1030	Noun_Phrase 27765 27784	the Xpd†XPCS allele
T1031	Noun_Phrase 27765 27905	the Xpd†XPCS allele imparted a clear UV survival benefit over a single XpdTTD allele or two XpdXPCS alleles independent of expression levels
T1032	IDENTITY_chain 27765 27905	the Xpd†XPCS allele imparted a clear UV survival benefit over a single XpdTTD allele or two XpdXPCS alleles independent of expression levels
T1033	Noun_Phrase 27769 27777	Xpd†XPCS
T1034	Noun_Phrase 27836 27842	XpdTTD
T1035	Noun_Phrase 27857 27864	XpdXPCS
T1036	Noun_Phrase 27932 27960	interallelic complementation
T1037	Noun_Phrase 28064 28077	XpdTTD/ †XPCS
T1038	Noun_Phrase 28112 28180	this repair activity in the rescue of TTD progeroid symptoms in vivo
T1039	Noun_Phrase 28150 28153	TTD
T1040	Noun_Phrase 28183 28211	Interallelic Complementation
T1041	Noun_Phrase 28216 28219	XPD
T1042	Noun_Phrase 28240 28268	interallelic complementation
T1043	Noun_Phrase 28300 28303	XPD
T1044	Noun_Phrase 28314 28342	Interallelic complementation
T1045	Noun_Phrase 28512 28515	XPD
T1046	Noun_Phrase 28581 28584	XPD
T1047	Noun_Phrase 28593 28596	its
T1048	Noun_Phrase 28618 28623	TFIIH
T1049	Noun_Phrase 28725 28730	TFIIH
T1050	Noun_Phrase 28743 28746	XPD
T1051	Noun_Phrase 28751 28754	XPB
T1052	Noun_Phrase 28770 28773	NER
T1053	Nonreferential_pronoun 28798 28800	it
T1054	Noun_Phrase 28816 28821	TFIIH
T1055	Noun_Phrase 28826 28829	its
T1056	Noun_Phrase 28897 28900	NER
T1057	Noun_Phrase 28924 28927	XPD
T1058	Noun_Phrase 28972 28977	TFIIH
T1059	Noun_Phrase 28979 28981	27
T1060	IDENTITY_chain 28979 28981	27
T1061	Noun_Phrase 28984 28986	We
T1062	Noun_Phrase 29028 29056	interallelic complementation
T1063	Noun_Phrase 29084 29087	XPD
T1064	Noun_Phrase 29109 29114	TFIIH
T1065	Noun_Phrase 29138 29143	TFIIH
T1066	Noun_Phrase 29175 29178	XPD
T1067	Noun_Phrase 29367 29370	XPD
T1068	Noun_Phrase 29418 29431	presumed null
T1069	IDENTITY_chain 29418 29431	presumed null
T1070	Noun_Phrase 29418 29439	presumed null alleles
T1071	IDENTITY_chain 29418 29439	presumed null alleles
T1072	Noun_Phrase 29488 29507	basal transcription
T1073	Noun_Phrase 29509 29511	27
T1074	Noun_Phrase 29549 29562	these alleles
T1075	Noun_Phrase 29617 29621	null
T1076	Noun_Phrase 29634 29657	the XPD homologue rad15
T1077	Noun_Phrase 29638 29641	XPD
T1078	Noun_Phrase 29659 29661	19
T1079	Noun_Phrase 29664 29667	Our
T1080	Noun_Phrase 29664 29672	Our data
T1081	Noun_Phrase 29686 29715	certain presumed null alleles
T1082	IDENTITY_chain 29686 29715	certain presumed null alleles
T1083	Noun_Phrase 29686 29894	certain presumed null alleles, although unable on their own to support basal transcription, may in fact have a substantial impact on disease outcome in compound heterozygous humans, as they do in mouse models
T1084	IDENTITY_chain 29686 29894	certain presumed null alleles, although unable on their own to support basal transcription, may in fact have a substantial impact on disease outcome in compound heterozygous humans, as they do in mouse models
T1085	Noun_Phrase 29694 29707	presumed null
T1086	Noun_Phrase 29736 29741	their
T1087	Noun_Phrase 29757 29776	basal transcription
T1088	Noun_Phrase 29871 29875	they
T1089	Noun_Phrase 29882 29887	mouse
T1090	Noun_Phrase 29929 29944	this hypothesis
T1091	Noun_Phrase 29968 29970	XP
T1092	Noun_Phrase 29968 30003	XP complementation group D patients
T1093	IDENTITY_chain 29968 30003	XP complementation group D patients
T1094	Noun_Phrase 30080 30083	XPD
T1095	Noun_Phrase 30095 30103	Figure 5
T1096	IDENTITY_chain 30095 30103	Figure 5
T1097	Noun_Phrase 30121 31222	two hemizygous XPDXPCS patients carrying the XPDG47R- or XPDR666W-encoding alleles who died of the disease before 2 y of age, two compound heterozygous XPDXPCS patients carrying the same XPDG47R- or XPDR666W-encoding alleles in addition to the presumed null XPDL461V+del716−730 both had considerably milder disease symptoms and survived more than ten times longer (A. Lehmann, personal communication) (Figure 5). Compound heterozygosity is also associated with the recently reported combination XP and TTD (XPTTD) syndrome [8]. Similar to the XpdTTD/†XPCS and XpdTTD/†XP mice described here, both patients with XPTTD described so far had intermediate hair cysteine values. Furthermore, XPTTD patient XP38BR carried a “causative” TTD mutation in one allele and a novel point mutation encoding XPDL485P in the other. Although the XPDL485P-encoding allele fails to complement viability in the haploid S. pombe rad15 deletion strain and is thus interpretable as a null allele [8], we nonetheless suggest that the combined XPTTD phenotype in this patient involves phenotypic contributions from both alleles
T1098	IDENTITY_chain 30121 31222	two hemizygous XPDXPCS patients carrying the XPDG47R- or XPDR666W-encoding alleles who died of the disease before 2 y of age, two compound heterozygous XPDXPCS patients carrying the same XPDG47R- or XPDR666W-encoding alleles in addition to the presumed null XPDL461V+del716−730 both had considerably milder disease symptoms and survived more than ten times longer (A. Lehmann, personal communication) (Figure 5). Compound heterozygosity is also associated with the recently reported combination XP and TTD (XPTTD) syndrome [8]. Similar to the XpdTTD/†XPCS and XpdTTD/†XP mice described here, both patients with XPTTD described so far had intermediate hair cysteine values. Furthermore, XPTTD patient XP38BR carried a “causative” TTD mutation in one allele and a novel point mutation encoding XPDL485P in the other. Although the XPDL485P-encoding allele fails to complement viability in the haploid S. pombe rad15 deletion strain and is thus interpretable as a null allele [8], we nonetheless suggest that the combined XPTTD phenotype in this patient involves phenotypic contributions from both alleles
T1099	Noun_Phrase 30136 30143	XPDXPCS
T1100	Noun_Phrase 30162 30165;30178 30203	the XPDR666W-encoding alleles
T1101	IDENTITY_chain 30162 30165;30178 30203	the XPDR666W-encoding alleles
T1102	Noun_Phrase 30162 30174;30187 30203	the XPDG47R- encoding alleles
T1103	IDENTITY_chain 30162 30174;30187 30203	the XPDG47R- encoding alleles
T1104	Noun_Phrase 30162 30203	the XPDG47R- or XPDR666W-encoding alleles
T1105	IDENTITY_chain 30162 30203	the XPDG47R- or XPDR666W-encoding alleles
T1106	Noun_Phrase 30273 30280	XPDXPCS
T1107	Noun_Phrase 30299 30307;30320 30345	the same XPDR666W-encoding alleles
T1108	Noun_Phrase 30299 30316;30329 30345	the same XPDG47R- encoding alleles
T1109	Noun_Phrase 30299 30345	the same XPDG47R- or XPDR666W-encoding alleles
T1110	Noun_Phrase 30365 30378	presumed null
T1111	Noun_Phrase 30523 30531	Figure 5
T1112	Noun_Phrase 30534 30557	Compound heterozygosity
T1113	Noun_Phrase 30616 30618	XP
T1114	APPOS_relation 30616 30626;30635 30643	XP and TTD syndrome
T1115	IDENTITY_chain 30616 30626;30635 30643	XP and TTD syndrome
T1116	Noun_Phrase 30616 30626;30635 30643	XP and TTD syndrome
T1117	Noun_Phrase 30623 30626	TTD
T1118	Noun_Phrase 30628 30633	XPTTD
T1119	Noun_Phrase 30645 30646	8
T1120	Noun_Phrase 30660 30676;30692 30696	the XpdTTD/†XPCS mice
T1121	Noun_Phrase 30664 30676	XpdTTD/†XPCS
T1122	Noun_Phrase 30681 30691	XpdTTD/†XP
T1123	Noun_Phrase 30732 30737	XPTTD
T1124	Noun_Phrase 30807 30812	XPTTD
T1125	Noun_Phrase 30807 30827	XPTTD patient XP38BR
T1126	IDENTITY_chain 30807 30827	XPTTD patient XP38BR
T1127	Noun_Phrase 30850 30853	TTD
T1128	Noun_Phrase 31081 31085	null
T1129	Noun_Phrase 31094 31095	8
T1130	Noun_Phrase 31098 31100	we
T1131	Noun_Phrase 31139 31144	XPTTD
T1132	Noun_Phrase 31158 31170	this patient
T1133	Noun_Phrase 31240 31250	these data
T1134	Noun_Phrase 31317 31355	patients in XP complementation group D
T1135	Noun_Phrase 31329 31331	XP
T1136	Noun_Phrase 31358 31366	Figure 5
T1137	Noun_Phrase 31368 31386	Genotype–Phenotype
T1138	IDENTITY_chain 31368 31386	Genotype–Phenotype
T1139	Noun_Phrase 31404 31407	XPD
T1140	Noun_Phrase 31468 31477	phenotype
T1141	Noun_Phrase 31535 31561	a second, different allele
T1142	IDENTITY_chain 31535 31561	a second, different allele
T1143	Noun_Phrase 31574 31576	it
T1144	Nonreferential_pronoun 31610 31615	There
T1145	Noun_Phrase 31669 31672	XPD
T1146	Noun_Phrase 31710 31712	We
T1147	Noun_Phrase 31888 31901	presumed null
T1148	Noun_Phrase 31888 31908	presumed null allele
T1149	Noun_Phrase 32209 32216	Mammals
T1150	Noun_Phrase 32221 32227	humans
T1151	Noun_Phrase 32255 32272	biallelic effects
T1152	Noun_Phrase 32281 32309	interallelic complementation
T1153	Noun_Phrase 32388 32394	mutant
T1154	Noun_Phrase 32592 32595	our
T1155	Noun_Phrase 32731 32759	interallelic complementation
T1156	Noun_Phrase 32774 32779	human
T1157	Noun_Phrase 33165 33167	We
T1158	Noun_Phrase 33176 33193	biallelic effects
T1159	Noun_Phrase 33263 33281	genotype–phenotype
T1160	Noun_Phrase 33363 33370	mammals
T1161	Noun_Phrase 33558 33561	our
T1162	Noun_Phrase 33558 33566	our data
T1163	Noun_Phrase 33647 33651	null
T1164	Noun_Phrase 33735 33744	phenotype
T1165	Noun_Phrase 33797 33803	mutant
T1166	Noun_Phrase 33825 33831	XpdTTD
T1167	Noun_Phrase 33825 33831;33857 33861	XpdTTD mice
T1168	APPOS_relation 33825 33831;33857 33861	XpdTTD mice
T1169	Noun_Phrase 33833 33841	XPDR722W
T1170	Noun_Phrase 33847 33856	XpdTTD/KO
T1171	Noun_Phrase 33893 33895	21
T1172	Noun_Phrase 33896 33898	22
T1173	Noun_Phrase 33970 33978	Xpd†XPCS
T1174	Noun_Phrase 33983 33990	Xpd †XP
T1175	Noun_Phrase 34108 34113	mouse
T1176	Noun_Phrase 34164 34183	standard procedures
T1177	IDENTITY_chain 34164 34183	standard procedures
T1178	Noun_Phrase 34244 34263	standard procedures
T1179	Noun_Phrase 34265 34284	Amino acid analysis
T1180	Noun_Phrase 34316 34318	21
T1181	Noun_Phrase 34321 34326	Blood
T1182	Noun_Phrase 34508 34510	15
T1183	Noun_Phrase 34526 34536	this study
T1184	IDENTITY_chain 34526 34536	this study
T1185	Noun_Phrase 34630 34634	mice
T1186	Noun_Phrase 34832 34834	UV
T1187	Noun_Phrase 34848 34854	UV-UDS
T1188	Noun_Phrase 34856 34862	UV-RRS
T1189	Noun_Phrase 34868 34873	TFIIH
T1190	Noun_Phrase 34903 34905	UV
T1191	Noun_Phrase 34903 34914	UV survival
T1192	Noun_Phrase 34916 34922	UV-UDS
T1193	Noun_Phrase 34928 34934	UV-RRS
T1194	Noun_Phrase 34982 34984	21
T1195	Noun_Phrase 34994 35000	UV-RRS
T1196	Noun_Phrase 35067 35069	wt
T1197	Noun_Phrase 35077 35087	XpdTTD/TTD
T1198	Noun_Phrase 35093 35104	XpdTTD/XPCS
T1199	Noun_Phrase 35158 35164	UV-UDS
T1200	Noun_Phrase 35184 35194	this study
T1201	Noun_Phrase 35199 35209	XpdTTD/TTD
T1202	Noun_Phrase 35199 35215	XpdTTD/TTD cells
T1203	Noun_Phrase 35229 35232	our
T1204	Noun_Phrase 35274 35276	21
T1205	Noun_Phrase 35439 35456	recombinant TFIIH
T1206	Noun_Phrase 35507 35509	27
T1207	Noun_Phrase 35513 35543	Comparative immunofluorescence
T1208	IDENTITY_chain 35513 35543	Comparative immunofluorescence
T1209	Noun_Phrase 35571 35601	comparative immunofluorescence
T1210	Noun_Phrase 35618 35642	p62 subunit of the TFIIH
T1211	Noun_Phrase 35637 35642	TFIIH
T1212	Noun_Phrase 35682 35684	16
T1213	Noun_Phrase 35685 35687	17
T1214	Noun_Phrase 35703 35708	mouse
T1215	Noun_Phrase 35800 35810	XpdTTD/†XP
T1216	Noun_Phrase 35800 35816	XpdTTD/†XP cells
T1217	Noun_Phrase 35964 35966	We
T1218	Noun_Phrase 36183 36186	JOA
T1219	IDENTITY_chain 36183 36186	JOA
T1220	Noun_Phrase 36188 36190	JJ
T1221	IDENTITY_chain 36188 36190	JJ
T1222	Noun_Phrase 36192 36196	JHJH
T1223	IDENTITY_chain 36192 36196	JHJH
T1224	Noun_Phrase 36198 36204	GTJvdH
T1225	IDENTITY_chain 36198 36204	GTJvdH
T1226	Noun_Phrase 36210 36213	JRM
T1227	IDENTITY_chain 36210 36213	JRM
T1228	Noun_Phrase 36254 36257	JOA
T1229	Noun_Phrase 36259 36261	JJ
T1230	Noun_Phrase 36263 36266	JdW
T1231	IDENTITY_chain 36263 36266	JdW
T1232	Noun_Phrase 36268 36270	FC
T1233	IDENTITY_chain 36268 36270	FC
T1234	Noun_Phrase 36272 36274	DH
T1235	IDENTITY_chain 36272 36274	DH
T1236	Noun_Phrase 36276 36280	MvdV
T1237	IDENTITY_chain 36276 36280	MvdV
T1238	Noun_Phrase 36286 36288	JH
T1239	IDENTITY_chain 36286 36288	JH
T1240	Noun_Phrase 36290 36294	WJvL
T1241	IDENTITY_chain 36290 36294	WJvL
T1242	Noun_Phrase 36300 36303	JRM
T1243	Noun_Phrase 36331 36334	JOA
T1244	Noun_Phrase 36336 36338	JJ
T1245	Noun_Phrase 36340 36343	JdW
T1246	Noun_Phrase 36345 36347	FC
T1247	Noun_Phrase 36349 36351	DH
T1248	Noun_Phrase 36353 36357	MvdV
T1249	Noun_Phrase 36359 36361	JH
T1250	Noun_Phrase 36368 36372	WJvL
T1251	Noun_Phrase 36379 36383	JHJH
T1252	Noun_Phrase 36389 36392	JRM
T1253	Noun_Phrase 36402 36410	the data
T1254	Noun_Phrase 36420 36426	GTJvdH
T1255	Noun_Phrase 36474 36477	JOA
T1256	Noun_Phrase 36479 36483	JHJH
T1257	Noun_Phrase 36489 36492	JRM
T1258	Noun_Phrase 36520 36533	This research
T1259	Noun_Phrase 36555 36603	Netherlands Organization for Scientific Research
T1260	APPOS_relation 36555 36603	Netherlands Organization for Scientific Research
T1261	Noun_Phrase 36605 36608	NWO
T1262	Noun_Phrase 36916 36919	JRM
T1263	Noun_Phrase 37002 37004	bp
T1264	APPOS_relation 37002 37004	bp
T1265	Noun_Phrase 37007 37016	base pair
T1266	Noun_Phrase 37018 37020	CS
T1267	APPOS_relation 37018 37020	CS
T1268	Noun_Phrase 37023 37040	Cockayne syndrome
T1269	Noun_Phrase 37042 37051	E[number]
T1270	APPOS_relation 37042 37051	E[number]
T1271	Noun_Phrase 37054 37076	embryonic day [number]
T1272	Noun_Phrase 37078 37080	kb
T1273	APPOS_relation 37078 37080	kb
T1274	Noun_Phrase 37083 37091	kilobase
T1275	Noun_Phrase 37093 37096	NER
T1276	APPOS_relation 37093 37096	NER
T1277	Noun_Phrase 37099 37125	nucleotide excision repair
T1278	Noun_Phrase 37127 37130	SEM
T1279	APPOS_relation 37127 37130	SEM
T1280	Noun_Phrase 37133 37159	standard error of the mean
T1281	Noun_Phrase 37161 37166	TFIIH
T1282	APPOS_relation 37161 37166	TFIIH
T1283	Noun_Phrase 37169 37210	basal transcription/DNA repair factor IIH
T1284	Noun_Phrase 37212 37215	TTD
T1285	APPOS_relation 37212 37215	TTD
T1286	Noun_Phrase 37218 37237	trichothiodystrophy
T1287	Noun_Phrase 37239 37245	UV-RRS
T1288	APPOS_relation 37239 37245	UV-RRS
T1289	Noun_Phrase 37248 37303	recovery of RNA synthesis after ultraviolet irradiation
T1290	Noun_Phrase 37305 37311	UV-UDS
T1291	APPOS_relation 37305 37311	UV-UDS
T1292	Noun_Phrase 37314 37369	unscheduled DNA synthesis after ultraviolet irradiation
T1293	Noun_Phrase 37371 37373	wt
T1294	APPOS_relation 37371 37373	wt
T1295	Noun_Phrase 37376 37385	wild-type
T1296	Noun_Phrase 37387 37389	XP
T1297	APPOS_relation 37387 37389	XP
T1298	Noun_Phrase 37392 37413	xeroderma pigmentosum
T1299	Noun_Phrase 37415 37419	XPCS
T1300	APPOS_relation 37415 37419	XPCS
T1301	Noun_Phrase 37422 37475	xeroderma pigmentosum combined with Cockayne syndrome
T1302	Noun_Phrase 37477 37482	XPTTD
T1303	APPOS_relation 37477 37482	XPTTD
T1304	Noun_Phrase 37485 37542	combination xeroderma pigmentosum and trichothiodystrophy
T1305	Noun_Phrase 37576 37587	The authors
